article thumbnail

Qualifyze secures funds to transform pharma supply chain compliance

Pharmaceutical Technology

Qualifyze has secured $12m to improve supply chain compliance in the pharmaceutical sector using technological and audit data.

article thumbnail

Compliance standards in medicines are evolving rapidly. How can CDMOs keep up?  

Pharmaceutical Technology

CDMOs face growing challenges to keep up with QA and compliance. The regulatory framework governing medicine development is in flux.

Medicine 130

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The criticality of compliance


Prior to selling drugs or medical products in any country, pharmaceutical companies must prove compliance and gain the regulatory approval required by the country in which the goods will be distributed in. So, with mandates in place, how do manufacturing facilities meet these compliance goals? The dominion of data.

article thumbnail

NABL issues clarification on CAB combined ILAC MRA mark for effective compliance

AuroBlog - Aurous Healthcare Clinical Trials blog

The National Accreditation Board for Testing and Calibration Laboratories (NABL) has issued clarification on NABL accredited Conformity Assessment Body (CAB) combined International Laboratory Accreditation Co-operation (ILAC) Mutual Recognition Arrangement (MRA) mark for effective compliance.

article thumbnail

Is Apple that naive when it comes to compliance?

World of DTC Marketing

There are many reasons for non-compliance and non-adherence: Cost and affordability, lack of understanding/comprehension of advice, language barriers, cognitive abilities, fear of asking for clarification, or other reasons. The post Is Apple that naive when it comes to compliance? Oh, to live in an ideal world.

article thumbnail

What is Going on in Billing Compliance for Clinical Trials?

ACRP blog

Clinical trial billing compliance—ensuring that charges for therapies and other study-related elements are sent to the appropriate party—is a key concern for academic medical centers and other research organizations. She concluded that “a proactive approach to clinical trial billing compliance can help mitigate these risks.”

article thumbnail

Altro Pharmaceuticals, LSPedia Team Up on DSCSA Compliance

Pharmaceutical Commerce

With FDA’s compliance deadline only three months away, the tech-supply chain partnership is expected to help manufacturers and wholesalers meet the Nov. 27 deadline.